Asimov
Intelligent design of living systems
Boston, United States · Founded 2017 · $175.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2017
- Business Model
- SaaS
- Website
- asimov.com
- Total Funding
- $175.0M
- Last Round
- $175.0M Series BJan 2023
- Rounds
- 1
About
Asimov builds an integrated platform of cells, genes, and cloud-based design software to enable advanced genetic design and biomanufacturing for biologics, cell therapies, and gene therapies. It provides GMP host cells, genetic parts libraries, and AI-driven tools for therapeutic production.
Summary
Asimov is a Healthcare company based in Boston, United States, founded in 2017. It has raised $175.0M in total across 1 round, most recently a $175.0M Series B round in Jan 2023. Investors include Canada Pension Plan Investment Board and Andreessen Horowitz.
Tech & App Stack
11 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2023
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...